Friday, July 10, 2026

Drug profile · INN

probiotics

probiotics is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 3
Pipeline programs 17
News articles 0
Drug details — probiotics
Class
Route
Patents
3
Programs
17
Data quality
0.70

Quick answer

probiotics is an FDA-listed pharmaceutical active ingredient.

Key facts

INN probiotics

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. probiotic strain Bb-12 Phase 3 · United Therapeutics Europe · Infections, Respiratory
  2. probiotics, antibiotics or antidepressants Phase 3 · First People's Hospital · Irritable Bowel Syndrome
  3. Placebo Phase 2 · Acadia Pharmaceuticals · Anxiety
  4. Probiotics Compound (Biolosion) Phase 2 · Sun Yat-sen University · Advanced Urothelial Carcinoma
  5. Probiotic Phase 1 · First People's Hospital · Microbiota
  6. Probiotics Approved · Chinese Academy of · Chronic Kidney Disease
  7. Akkermansia Probiotics Unknown · Chinese Academy of · Colo-rectal Cancer
  8. Probiotic Unknown · United Therapeutics Europe · Stress Physiology

Related patents

  1. US 11607435

    Probiotics Bifidobacteria strains

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11446342

    Composite probiotics and use thereof

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9855305

    Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is probiotics?

probiotics is an FDA-listed pharmaceutical active ingredient.